EZH2在固体瘤转移中的新兴作用
Ayushi Verma1, Muqtada Ali Khan1, Saumya Ranjan Satrusal2
1Division of Cancer Biology, CSIR-Central Drug Research Institute (CDRI), Lucknow 226031, India.
Biochimica et biophysica acta. Reviews on cancer
|December 26, 2024
概括
可逆表观遗传重编程,驱动的增强器的Zeste同源2 (EZH2),是癌症转移的关键. 这项研究探讨了EZH2的存在.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 癌细胞在转移过程中发生可逆变化.
- 表观遗传重编程是癌症传播的关键驱动因素.
- 增强Zeste同源2 (EZH2) 的增强剂与表观遗传重编程有关.
研究的目的:
- 检查EZH2在固体瘤转移中的多方面的作用.
- 研究向EZH2在转移中的治疗潜力.
- 了解EZH2和H3K27me3在转移中的二分基因调节作用.
主要方法:
- 对EZH2和癌症转移的现有文献的综述.
- 分析涉及EZH2和H3K27me3.3的基因调节机制.
- 探索针对EZH2.2的治疗策略.
主要成果:
- EZH2蛋白及其催化功能 (H3K27me3) 促进了固体瘤的转移.
- 在某些癌症中,EZH2抑制对原发性瘤生长的影响有限.
- EZH2和H3K27me3的异构基因调节作用有助于转移.
结论:
- EZH2在调节固体瘤转移方面发挥着重要且多方面的作用.
- 了解EZH2的复杂功能对于开发有效的癌症疗法至关重要.
- 向EZH2为对抗癌症转移提供了潜在的治疗途径.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


